FDA NDC Directory · JSON-LD · Markdown

Bortezomib

NDC 51817-586 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic namebortezomib
Labeler / ManufacturerPharmascience Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA208392
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS SUBCUTANEOUS
Active ingredientsBORTEZOMIB (3.5 mg/1)
Marketing started20220502
Package count1

External sources

Source: openFDA. Public-domain (CC0).